Evidence map›Paper›PMID 40830782›Full record

SynthesisBMC public health2025

Cervical cancer screening uptake in East Africa: a systematic review and meta-analysis of observational studies.

Hiwot Tezera Endale, Habtu Kifle Negash, Mihret Getnet, Tseganesh Asefa, Yibeltal Yismaw Gela, Winta Tesfaye, Hailu Aragie

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiwot Tezera EndaleDepartment of Medical Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. hiwottezera1@gmail.com.
Habtu Kifle NegashDepartment of Human Anatomy, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Mihret GetnetDepartment of Epidemiology and biostatistics, Institute of public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Tseganesh AsefaDepartment of Medical Nursing, School of Nursing, College of Medicine and Health sciences, University of Gondar, Gondar, Ethiopia.
Yibeltal Yismaw GelaDepartment of Human Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Winta TesfayeDepartment of Human Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Hailu AragieDepartment of Medical Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is the second most common cancer and the leading cause of cancer-related deaths among women of reproductive age globally. In East Africa, cervical cancer presents a substantial public health challenge. Although previous studies have attempted to assess its prevalence and determine the associated factors, their findings have often been inconsistent and inconclusive. To address this gap, we conducted this systematic review and meta-analysis, aiming to provide clearer insights into the prevalence and determinants of cervical cancer screening in the region.

methodThe review protocol was registered in PROSPERO under the reference number CRD42024563102. We systematically searched of multiple databases, including PubMed, Hinari, Embase, Scopus, Epistimonikos, African Journals Online, ScienceDirect, and Google Scholar. We included observational studies published between January 1, 2019, and September 2, 2024. The search results were retrieved and organized using Rayyan software. The data analysis was done using Stata version 17 software. The heterogeneity and publication bias were assessed prior to pooling the estimates.

resultA total of 12,700 women included from 24 articles. The overall estimated pooled prevalence of cervical cancer screening was 19.22% (95% CI 14.69, 23.74). Age 40–49 years (AOR = 2.58; 95% CI: 1.41, 4.73), government employment (AOR = 1.55; 95% CI: 0.61, 3.93), marriage (AOR = 0.82, 95% CI: 0.15, 4.46), divorce (AOR = 2.32, 95% CI: 0.13, 43.54), parity of more than four (AOR = 1.4; 95% CI: 0.5, 3.93), good knowledge (AOR = 4.31; 95% CI: 2.72, 6.83), high perceived severity (AOR = 1.63; 95% CI: 0.63, 4.22), high perceived benefit (AOR = 1.73; 95% CI: 0.98, 3.05), low perceived barriers (AOR = 2.25; 95% CI: 0.77, 6.60), modern contraceptives use (AOR = 1.18; 95% CI: 0.52, 2.65), know someone with cervical cancer (AOR = 2.12; 95% CI: 0.70, 6.40), and favorable attitude (AOR = 2.63; 95% CI: 1.66, 4.17) were significantly associated with cervical cancer screening utilization.

conclusionCervical cancer screening uptake remains low in East Africa due to factors like demographics, knowledge, attitudes, and personal connections to the disease. Empowering women and enhancing their knowledge, attitudes, and perceptions are essential strategies to improve screening practices.

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsAfrica, EasternFemaleHumansObservational Studies as TopicCervical cancerEast africaScreening uptakeSystematic review and meta-analysis

Identifiers

PMID40830782
PMCPMC12363099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.